Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma
- PMID: 37526667
- DOI: 10.1007/s00330-023-10004-8
Clinical value of dual-energy CT for predicting occult metastasis in central neck lymph nodes of papillary thyroid carcinoma
Abstract
Objectives: To predict the probability of occult lymph node metastasis (OLNM) in the central cervical by analyzing the dual-energy computed tomography (DECT) parameters derived from papillary thyroid carcinoma (PTC).
Methods: Data were retrospectively collected from patients with pathologically confirmed PTC who underwent arterial and venous phases of enhanced DECT with concurrent central neck lymph node dissection (CLND). Three clinical features, three shape-related features, and twenty-six DECT-derived parameters were measured. The univariate and multivariate analyses were applied to select the relevant parameters and develop the nomogram.
Results: A total 140 cases with negative diagnosis of cervical central lymph node metastases by preoperative evaluation were included, among which 88 patients with metastasis (OLNM +) and 52 patients without metastasis (OLNM -) were finally confirmed by pathology. (1) Anteroposterior/transverse diameter ratio (A/T) derived from the PTC focus had significant difference between the OLNM + and OLNM - groups (p < 0.05). (2) In the arterial phase, iodine concentration (ICarterial), normalized iodine concentration (NICarterial), effective atomic number (Zeff-arterial), electron density (EDarterial), and slope of energy curve (karterial) from PTC focus showed significant difference (all p < 0.05) between the two groups. In the venous phase, only the CT value under the 40 keV (HU40keVvenous) had differences (p < 0.05). (3) The nomogram was produced to predict the probability of OLNM, and the AUC, sensitivity, and specificity in the training and test cohort were 0.830, 75.0%, 76.9%, and 0.829, 65.9%, 84.6%, respectively.
Conclusions: DECT parameters combined with shape-related feature derived from PTC might be used as predictors of OLNM in the central neck.
Clinical relevance statement: Preoperative imaging evaluation combining shape-related features and dual-energy CT parameters could serve as a reference to discern occult lymph node metastasis in central neck during the surgically planning of papillary thyroid carcinoma.
Key points: • Papillary thyroid carcinoma (PTC) patients may have occult lymph node metastasis (OLNM) in the central neck, which is extremely difficult to find by preoperative imaging examination. • Dual-energy CT quantitative evaluation has higher accuracy than conventional CT and can predicting OLNM in the central neck of PTC. • Dual-energy CT quantitative parameters and morphology of PTC can serve as a useful tool in predicting OLNM in the central neck, and as a guide for personalized treatment.
Keywords: Computed tomography; Lymph node; Lymph node metastasis; Papillary thyroid carcinoma.
© 2023. The Author(s), under exclusive licence to European Society of Radiology.
Similar articles
-
Dual-Energy Computed Tomography Parameters Combined With Inflammatory Indicators Predict Cervical Lymph Node Metastasis in Papillary Thyroid Cancer.Cancer Control. 2024 Jan-Dec;31:10732748241262177. doi: 10.1177/10732748241262177. Cancer Control. 2024. PMID: 38881040 Free PMC article.
-
Development and Validation of a Dual-Energy CT-Based Model for Predicting the Number of Central Lymph Node Metastases in Clinically Node-Negative Papillary Thyroid Carcinoma.Acad Radiol. 2024 Jan;31(1):142-156. doi: 10.1016/j.acra.2023.04.038. Epub 2023 Jun 4. Acad Radiol. 2024. PMID: 37280128
-
Preoperative assessment of cervical lymph node metastases in patients with papillary thyroid carcinoma: Incremental diagnostic value of dual-energy CT combined with ultrasound.PLoS One. 2021 Dec 13;16(12):e0261233. doi: 10.1371/journal.pone.0261233. eCollection 2021. PLoS One. 2021. PMID: 34898649 Free PMC article.
-
Diagnostic performance of dual-energy computed tomography (DECT) quantitative parameters for detecting metastatic cervical lymph nodes in patients with papillary thyroid cancer: A systematic review and meta-analysis.Eur J Radiol. 2025 Feb;183:111917. doi: 10.1016/j.ejrad.2025.111917. Epub 2025 Jan 3. Eur J Radiol. 2025. PMID: 39778378
-
A combination of computed tomography scan and ultrasound provides optimal detection of cervical lymph node metastasis in papillary thyroid carcinomas: A systematic review and meta-analysis.Head Neck. 2023 Sep;45(9):2173-2184. doi: 10.1002/hed.27451. Epub 2023 Jul 7. Head Neck. 2023. PMID: 37417426
Cited by
-
The preoperative prediction of lymph node metastasis of resectable pancreatic ductal adenocarcinoma using dual-layer spectral computed tomography.Eur Radiol. 2025 May;35(5):2692-2701. doi: 10.1007/s00330-024-11143-2. Epub 2024 Oct 24. Eur Radiol. 2025. PMID: 39448418
-
Is prophylactic central neck dissection necessary for patients with clinically node-negative papillary thyroid microcarcinoma? A follow-up study of more than 10 years.Front Endocrinol (Lausanne). 2025 May 16;16:1597661. doi: 10.3389/fendo.2025.1597661. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40453583 Free PMC article.
-
The diagnostic performance of dual-energy CT imaging in cervical lymph node metastasis of papillary thyroid cancer: a meta-analysis.Front Med (Lausanne). 2024 Nov 6;11:1457307. doi: 10.3389/fmed.2024.1457307. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39568751 Free PMC article. Review.
-
Development and validation of a nomogram for preoperative prediction of ipsilateral cervical central lymph node metastasis in papillary thyroid cancer: a population-based study.Gland Surg. 2024 Apr 29;13(4):528-539. doi: 10.21037/gs-23-478. Epub 2024 Apr 22. Gland Surg. 2024. PMID: 38720676 Free PMC article.
-
Dual-energy CT to evaluate the infiltration status of tumor-associated macrophage (TAM) in gastric cancer: a preliminary study.Abdom Radiol (NY). 2025 Aug 11. doi: 10.1007/s00261-025-05153-x. Online ahead of print. Abdom Radiol (NY). 2025. PMID: 40788577
References
-
- Kowalska A, Walczyk A, Kowalik A et al (2016) Increase in papillary thyroid cancer incidence is accompanied by changes in the frequency of the BRAF V600E mutation: a single-institution study. Thyroid 26:543–551. https://doi.org/10.1089/thy.2015.0352 - DOI - PubMed
-
- Lee YK, Hong N, Shin DY et al (2019) The relationship of comorbidities to mortality and cause of death in patients with differentiated thyroid carcinoma. Sci Rep 9:11435. https://doi.org/10.1038/s41598-019-47898-8 - DOI - PubMed - PMC
-
- Xu Y, Xu L, Wang J (2018) Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. J Surg Res 221:128–134. https://doi.org/10.1016/j.jss.2017.08.007 - DOI - PubMed
-
- Meler-Claramonte C, Avilés-Jurado FX, Vilaseca I et al (2022) Semaphorin-3F/neuropilin-2 transcriptional expression as a predictive biomarker of occult lymph node metastases in HNSCC. Cancers (Basel) 14:2259. https://doi.org/10.3390/cancers14092259 - DOI - PubMed
-
- Lee J, Song Y, Soh EY (2014) Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma. J Korean Med Sci 29:48–52. https://doi.org/10.3346/jkms.2014.29.1.48 - DOI - PubMed
MeSH terms
Substances
Grants and funding
- 2019FE001 (-213)/The Joint Program of Yunnan Provincial Scienceand Technology Department and Kunming Medical University
- 202001AY070001-201/The Joint Program of Yunnan Provincial Scienceand Technology Department and Kunming Medical University
- 81960310/National Natural Science Foundation of China
- Z-2014-07-2101/The China Foundation for International Exchange 2021 SKY Imaging Research Found
LinkOut - more resources
Full Text Sources
Medical